Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort

Comparison of Survival Between Primary Debulking Surgery Versus Neoadjuvant Chemotherapy for Ovarian Cancers in a Personalized Treatment Cohort

ObjectiveTo compare survival between primary debulking surgery (PDS) and neoadjuvant chemotherapy (NACT) for the treatment of ovarian cancer patients per our selective protocol.MethodsBetween Sep 1st, 2015, and Aug 31st, 2017, 161 patients were enrolled in our prospective cohort. All of the patients...

Full description

Bibliographic Details
Main Authors: Zheng Feng, Hao Wen, Ruimin Li, Shuai Liu, Yi Fu, Xiaojun Chen, Rui Bi, Xingzhu Ju, Xiaohua Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
ovarian cancer
primary debulking surgery
neoadjuvant chemotherapy
residual disease
progression-free survival
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.632195/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.632195/full

Similar Items